Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2022-12-01 | 2023-04-28 | 176779 |
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2022-12-01 | 2023-04-28 | 176794 |
| TEVA-NAPROXEN EC | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2023-04-27 | 2023-06-09 | 190740 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-06-08 | 2023-06-21 | 194094 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2021-10-14 | 2022-02-17 | 147219 |
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2021-12-02 | 2022-02-10 | 150403 |
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2020-09-24 | 2020-10-22 | 124986 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-07-04 | 2023-07-14 | 197052 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-10-05 | 2023-12-14 | 206392 |
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2020-03-26 | 2020-05-08 | 109583 |
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2024-01-11 | 2024-03-18 | 215719 |
| TEVA-NAPROXEN SODIUM | 275MG | TABLET | Resolved | 2024-11-08 | 2025-01-09 | 242341 |
| TEVA-NAPROXEN SODIUM | 275MG | TABLET | Resolved | 2021-10-21 | 2021-11-05 | 147708 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Actual shortage | 2025-04-24 | 2025-04-24 | 255684 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2023-10-19 | 2023-11-09 | 207509 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2022-05-05 | 2022-06-04 | 160072 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118954 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-04-03 | 2020-04-09 | 110752 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2021-01-22 | 2021-03-18 | 132257 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140669 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 |